Yuping Zhang

6PUBLICATIONS
53CO-AUTHORS
Predictive and prognostic markersMolecular targetsInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 07, 2026
A ligandable PNT domain establishes ERG as a directly targetable oncogenic driver in prostate cancer.

|Aug 25, 2025
Cellular cartography reveals mouse prostate organization and determinants of castration resistance.

Hanbyul Cho, Yuping Zhang, Jean C Tien

|Jun 12, 2025
Defining CDK12 as a tumor suppressor and therapeutic target in mouse models of tubo-ovarian high-grade serous carcinoma.

Jean Ching-Yi Tien, Yali Zhai, Rong Wu

|Apr 24, 2025
Targeting PIKfyve-driven lipid metabolism in pancreatic cancer.

Caleb Cheng, Jing Hu, Rahul Mannan

|Nov 14, 2024
The UBA1-STUB1 Axis Mediates Cancer Immune Escape and Resistance to Checkpoint Blockade.

Yi Bao, Gabriel Cruz, Yuping Zhang

|Jun 28, 2024
PIKfyve, expressed by CD11c-positive cells, controls tumor immunity.

Jae Eun Choi, Yuanyuan Qiao, Ilona Kryczek

Pageof 1